Karyopharm Therapeutics
KPTI
#8602
Rank
€93.38 M
Marketcap
0,75 €
Share price
14.66%
Change (1 day)
-35.01%
Change (1 year)

EPS for Karyopharm Therapeutics (KPTI)

EPS in 2023 (TTM): -1,23 €

According to Karyopharm Therapeutics 's latest financial reports the company's current EPS (TTM) is -1,19 €. In 2022 the company made an earnings per share (EPS) of -1,83 € a decrease over its 2021 EPS that were of -1,50 €.

EPS history for Karyopharm Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-1,23 €-33.07%
2022-1,83 €22.29%
2021-1,50 €-39.19%
2020-2,46 €-15.48%
2019-2,91 €3.19%
2018-2,82 €11.79%
2017-2,53 €-4.44%
2016-2,64 €-11.75%
2015-3,00 €37.76%
2014-2,17 €-74.5%
2013-8,53 €

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
1,64 €-238.01%🇺🇸 USA
3,58 €-400.76%🇺🇸 USA
2,68 €-325.17%🇺🇸 USA
0,26 €-121.46%🇺🇸 USA